Page last updated: 2024-12-08

ro 136680

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-anisoyl-GABA: RN from Toxlit; structure given in first source; metabolite of aniracetam [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID155723
SCHEMBL ID2678159
MeSH IDM0185411

Synonyms (24)

Synonym
4-[(4-methoxyphenyl)formamido]butanoic acid
72432-14-5
EN300-36177
n-anisoyl-gaba
ro 13-6680
ro 136680
4-((4-methoxybenzoyl)amino)butanoic acid
butanoic acid, 4-((4-methoxybenzoyl)amino)-
STK396197
4-{[(4-methoxyphenyl)carbonyl]amino}butanoic acid
4-[(4-methoxybenzoyl)amino]butanoic acid
AKOS000127760
ro-136680
DTXSID60222721
4-(p-methoxybenzoylamino)butyric acid
DZTVZKSCFQIBMV-UHFFFAOYSA-N
SCHEMBL2678159
sr-01000359716
SR-01000359716-1
n-anisoyl-gamma-aminobutyric acid
CCG-295533
CS-0247258
4-[(4-methoxyphenyl)formamido]butanoicacid
Z85888837

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The validated method has been applied to the pharmacokinetic study after a single oral administration of aniracetam dispersible tablets to human beings."( Determination of aniracetam's main metabolite, N-anisoyl-GABA, in human plasma by LC-MS/MS and its application to a pharmacokinetic study.
Cai, S; Wang, L, 2012
)
0.38

Bioavailability

ExcerptReferenceRelevance
" The applicability and accuracy of the methods were demonstrated by the analysis of over 1000 plasma samples from two bioavailability studies in healthy volunteers."( Determination of aniracetam and its main metabolite, N-anisoyl-GABA, in human plasma by high-performance liquid chromatography.
Guenzi, A; Zanetti, M, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]